Difference between revisions of "Team:Linkoping Sweden/Improve"
| Line 58: | Line 58: | ||
<h4> | <h4> | ||
With the use of site-direted mutagenesis we wanted to improve the part of last years LiU iGEM team (BBa_K2474000). This was done by removing the fusion protein and the unnecessary bases as shown in figure 1. By doing this the fluorescent protein mNeonGreen (mNG) can be used as a reporter in a fully functional operone, with the use of the AraC/pBAD inducible system. The two additions was made with site-directed mutagenesis. Firstly the stop codon was added and sequenced, which was later used as the new template for the mutation to add the SpeI site. As seen in figure 1, we used SpeI to cleave off the unnecessary bases from the plasmid, and later ligated it back together without the amyloid-beta 1-42 fragment. </br> | With the use of site-direted mutagenesis we wanted to improve the part of last years LiU iGEM team (BBa_K2474000). This was done by removing the fusion protein and the unnecessary bases as shown in figure 1. By doing this the fluorescent protein mNeonGreen (mNG) can be used as a reporter in a fully functional operone, with the use of the AraC/pBAD inducible system. The two additions was made with site-directed mutagenesis. Firstly the stop codon was added and sequenced, which was later used as the new template for the mutation to add the SpeI site. As seen in figure 1, we used SpeI to cleave off the unnecessary bases from the plasmid, and later ligated it back together without the amyloid-beta 1-42 fragment. </br> | ||
| − | As seen in figure 2, our | + | As seen in figure 2, our mutated version had a higher intensity on a UV-table. |
</h4> | </h4> | ||
<img src="https://static.igem.org/mediawiki/2018/d/d1/T--Linkoping_Sweden--improve.jpg"></img> | <img src="https://static.igem.org/mediawiki/2018/d/d1/T--Linkoping_Sweden--improve.jpg"></img> | ||
| Line 70: | Line 70: | ||
<h4> | <h4> | ||
<i>Figure 2. From left to right: Reference, BBa_K2671000 (mutated part) and BBa_K2474000.</i> | <i>Figure 2. From left to right: Reference, BBa_K2671000 (mutated part) and BBa_K2474000.</i> | ||
| + | <h4/> | ||
| + | <h4> | ||
| + | Seen below in fig 3. is the chromatograms from sequencing. The results shows that the mutation GCC --> TAA was successful. The length of the sequence also suggest that amyloid-beta 1-42 was removed. Both parts was sequenced using the VR primer, and ~170 bases shorter fits perfectly with the legnth of the removed fragment. | ||
| + | <img src="https://static.igem.org/mediawiki/parts/c/c2/T--Linkoping_Sweden--chromatogram.png"></img> | ||
| + | <h4> | ||
| + | <i>Figure 3. The chromatograms from sequencing. Left is BBa_K2671000 (mutated part) and right is BBa_K2474000 (template).</i> | ||
<h4/> | <h4/> | ||
</div> | </div> | ||
Revision as of 15:11, 16 October 2018
Improve
Improvement of Liu iGEM 2017s part BBa_K2474000
With the use of site-direted mutagenesis we wanted to improve the part of last years LiU iGEM team (BBa_K2474000). This was done by removing the fusion protein and the unnecessary bases as shown in figure 1. By doing this the fluorescent protein mNeonGreen (mNG) can be used as a reporter in a fully functional operone, with the use of the AraC/pBAD inducible system. The two additions was made with site-directed mutagenesis. Firstly the stop codon was added and sequenced, which was later used as the new template for the mutation to add the SpeI site. As seen in figure 1, we used SpeI to cleave off the unnecessary bases from the plasmid, and later ligated it back together without the amyloid-beta 1-42 fragment. As seen in figure 2, our mutated version had a higher intensity on a UV-table.
